Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Jun;17(2):114-21.
doi: 10.3904/kjim.2002.17.2.114.

Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate

Affiliations

Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate

Min Seok Cho et al. Korean J Intern Med. 2002 Jun.

Abstract

Background: Patients on continuous ambulatory peritoneal dialysis (CAPD) have increased risk of low-turnover bone disease and relative hypoparathyroidism. Recently, it has been believed that magnesium plays an important role in regulating secretion of parathyroid hormone (PTH). The aim of this study was to evaluate the relationship between serum PTH and serum magnesium as a factor increasing the frequency of relative hypoparathyroidism.

Methods: We analyzed the data of 56 patients who had been on CAPD for more than 6 months without any significant problems. No patient had been previously treated with vitamin D or aluminum hydroxide. The patients had used peritoneal dialysate with the magnesium concentration of 0.5 mEq/L. Biochemical parameters, such as BUN, creatinine, alkaline phosphatase bony isoenzyme, total protein, albumin, total calcium, ionized calcium and intact parathyroid hormone level were measured.

Results: The mean serum magnesium level was 1.99 +/- 0.36 mEq/L. Among total 56 patients, 15 patients (26.8%) showed hypermagnesemia (serum magnesium > 2.2 mEq/L) and 5 patients (8.9%) showed hypomagnesemia (serum magnesium < 1.6 mEq/L). Among all 56 patients, serum iPTH (intact PTH) level was not correlated with serum magnesium level. However, it was inversely correlated with serum total calcium and ionized calcium levels, respectively (r = -0.365, p = 0.006; r = -0.515 p < 0.001). Among 49 patients whose serum iPTH level was less than 300 pg/mL, serum iPTH level was inversely correlated with serum magnesium level (r = -0.295, p = 0.039) and inversely correlated with serum total calcium and ionized calcium levels, respectively (r = -0.546, p < 0.001; r = -0.572 p < 0.001). Among 49 patients whose serum iPTH level was less than 300 pg/mL, lower iPTH group (serum iPTH < 120 pg/mL) showed higher serum magnesium level (p = 0.037), higher serum total calcium level (p < 0.001) and lower bone isoenzyme of alkaline phosphatase level (p < 0.001) than those of higher iPTH group (120 pg/mL < or = serum iPTH < 300 pg/mL).

Conclusion: Among the CAPD patients whose serum iPTH level was less than 300 pg/mL, there was a significant inverse correlation between serum iPTH level and serum magnesium level. This study indicates that not only serum calcium level but also serum magnesium level are important in the regulation of serum iPTH levels of CAPD patients who have been dialyzed by low-magnesium peritoneal dialysate.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Relationship between serum magnesium and iPTH levels in 56 CAPD patients (Pearson’s r=0.174, p=0.200)
Figure 2.
Figure 2.
Relationship between total serum calcium and iPTH levels in 56 CAPD patients (Pearson’s r=−0.365, p=0.006)
Figure 3.
Figure 3.
Relationship between serum ionized calcium and iPTH levels in 56 CAPD patients (Pearson’s r=−0.515, p<0.001)
Figure 4.
Figure 4.
Relationship between serum bone isoenzyme of alkaline phosphatase and iPTH levels in 56 CAPD patients (Pearson’s r=0.612, p<0.001)
Figure 5.
Figure 5.
Relationship between serum inorganic phosphate and iPTH levels in 56 CAPD patients (Pearson’s r=0.441, p=0.001).
Figure 6.
Figure 6.
Relationship between serum magnesium and iPTH levels in 49 CAPD patients whose serum iPTH levels are less than 300 pg/mL (Pearson’s r=−0.295, p=0.039)
Figure 7.
Figure 7.
Relationship between total serum calcium and iPTH levels in 49 CAPD patients whose serum iPTH levels are less than 300 pg/mL (Pearson’s r=−0.546, p<0.001)
Figure 8.
Figure 8.
Relationship between serum ionized calcium and iPTH levels in 49 CAPD patients whose serum iPTH levels are less than 300 pg/mL (Pearson’s r=−0.572, p<0.001)
Figure 9.
Figure 9.
Relationship between serum bone isoenzyme of alkaline phosphatase and iPTH levels in 49 CAPD patients whose serum iPTH levels are less than 300 pg/mL (Pearson’s r=0.615, p<0.001)
Figure 10.
Figure 10.
Relationship between serum inorganic phosphate and iPTH levels in 49 CAPD patients whose serum iPTH levels are less than 300 pg/mL (Pearson’s r=0.056, p=0.702)

Similar articles

Cited by

References

    1. Malluche HH, Faugere MC. Renal bone disease: an unmet challenge for the nephrologist. Kidney Int. 1990;38:193–211. - PubMed
    1. Couttenye MM, D’Haese PC, Verschoren WJ, Behets GJ, Schrooten I, De Broe ME. Low bone turnover in patients with renal failure. Kidney Int. 1999;56(Suppl 73):S70–S76. - PubMed
    1. Akizawa T, Kinugasa E, Akiba T, Tsukamoto Y, Kurokawa K. Incidence and clinical characteristics of hypoparathyroidism in dialysis patients. Kidney Int. 1997;52(Suppl 62):S72–S74. - PubMed
    1. Sherrard DJ, Hercz G, Pei Y, Maloney NA, Greenwood C, Manuel A, Saiphoo C, Fenton SS, Serge GV. The spectrum of bone disease in end-stage renal failure-an evolving disorder. Kidney Int. 1993;43:436–442. - PubMed
    1. Hercz G, Pei Y, Greenwood C, Manuel A, Saiphoo C, Goodman WG, Segre GV, Fenton S, Sherrard DJ. Aplastic osteodystrophy without aluminum: the role of "suppressed" parathyroid function. Kidney Int. 1993;44:860–866. - PubMed

LinkOut - more resources